Akebia Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Akebia Therapeutics

08/08/2024 14:32

* Akebia Therapeutics Inc  AKBA.OQ  reported a quarterly
adjusted
loss of 4 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -6 cents.  The mean expectation of
three analysts for the quarter was for a loss of 5 cents per
share. Wall Street expected results to range from -8 cents to -3
cents per share.
    * Revenue fell 22.6% to $43.65 million from a year ago;
analysts
expected $49.45 million. 
    * Akebia Therapeutics Inc's reported EPS for the quarter was
a
loss of 4 cents​.
    * The company reported a quarterly loss of $8.58 million.
    * Akebia Therapeutics Inc shares had risen by 8.8% this
quarter and lost 10.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Akebia
Therapeutics Inc is $5.00 
This summary was machine generated from LSEG data August 8 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.05          -0.04          Beat
 Mar. 31 2024      -0.08          -0.09          Missed
 Dec. 31 2023      -0.04          0.00           Beat
 Sep. 30 2023      -0.08          -0.08          Met